Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobby Chacko

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Kidney International Reports|May 29, 2026
Telitacicept in Recurrent IgA Nephropathy After Kidney Transplantation: Encouraging Signal, Cautious InterpretationBobby Chacko
Renal Failure|January 12, 2011
IgA nephropathy in India: what we do knowBobby Chacko
Clinical Transplantation|September 13, 2011
Clinical application of mTORi based immunosuppression for renal transplantation in IndiaBobby Chacko
Nephrology (Carlton, Vic.)|June 24, 2022
Severe hypocalcaemia following denosumab and iron infusionAdrienne Cohen, Bobby Chacko
Internal Medicine Journal|October 10, 2024
Immunoglobulin A nephropathy is not what it used to be!Shriram Swaminathan, Bobby Chacko
Australian Journal of General Practice|October 2, 2025
From microscopic haematuria to kidney failure: The hidden progression of IgA nephropathyShriram Swaminathan, Bobby Chacko
Internal Medicine Journal|July 26, 2022
'A disease of disparity': chronic kidney disease of unknown aetiology in endemic immigrant communitiesShriram Swaminathan, Bobby Chacko
Kidney International|November 21, 2017
The Case | Weeding out the cause of acute kidney injuryTheepika Rajkumar, Bobby Chacko
Nephrology (Carlton, Vic.)|May 9, 2025
Case Report: Something Is BrewingKate Brotherton, Bobby Chacko
Clinical Nephrology|June 23, 2018
Contrast-associated nephropathy: Does the route of administration matter?
Catherine Mao, Bobby Chacko
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Kidney International Reports|May 29, 2026
Telitacicept in Recurrent IgA Nephropathy After Kidney Transplantation: Encouraging Signal, Cautious InterpretationBobby Chacko
Renal Failure|January 12, 2011
IgA nephropathy in India: what we do knowBobby Chacko
Clinical Transplantation|September 13, 2011
Clinical application of mTORi based immunosuppression for renal transplantation in IndiaBobby Chacko
Nephrology (Carlton, Vic.)|June 24, 2022
Severe hypocalcaemia following denosumab and iron infusionAdrienne Cohen, Bobby Chacko
Internal Medicine Journal|October 10, 2024
Immunoglobulin A nephropathy is not what it used to be!Shriram Swaminathan, Bobby Chacko
Australian Journal of General Practice|October 2, 2025
From microscopic haematuria to kidney failure: The hidden progression of IgA nephropathyShriram Swaminathan, Bobby Chacko
Internal Medicine Journal|July 26, 2022
'A disease of disparity': chronic kidney disease of unknown aetiology in endemic immigrant communitiesShriram Swaminathan, Bobby Chacko
Kidney International|November 21, 2017
The Case | Weeding out the cause of acute kidney injuryTheepika Rajkumar, Bobby Chacko
Nephrology (Carlton, Vic.)|May 9, 2025
Case Report: Something Is BrewingKate Brotherton, Bobby Chacko
Clinical Nephrology|June 23, 2018
Contrast-associated nephropathy: Does the route of administration matter?
Catherine Mao, Bobby Chacko
Pageof 6